Atlas Trials

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

Clinical trial NCT00784537 · COMPLETED

Trial details

NCT number
NCT00784537
Sponsor
Fondazione Italiana Linfomi - ETS
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hodgkin's Lymphoma
Start date
2008-09-01
Primary completion
2015-01-01
Enrollment
520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.